United Therapeutics Oral Treprostinil (UT-15C SR) - Likelihood of clinical trial and commercial success - Product Thumbnail Image

United Therapeutics Oral Treprostinil (UT-15C SR) - Likelihood of clinical trial and commercial success

  • Report
  • 34 Pages
From
Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
HIV / AIDS - Pipeline Review, H1 2016 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2016

  • Report
  • 886 Pages
From
HIV / AIDS - Pipeline Review, H2 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H2 2015

  • Report
  • 916 Pages
From
HIV / AIDS - Pipeline Review, H1 2015 - Product Thumbnail Image

HIV / AIDS - Pipeline Review, H1 2015

  • Report
  • 871 Pages
From
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 67 Pages
From
Critical Limb Ischemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 149 Pages
From
Pulmonary Hypertension Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Pulmonary Hypertension Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 464 Pages
From
Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016 - Product Thumbnail Image

Pulmonary Arterial Hypertension Global Clinical Trials Review, H2, 2016

  • Clinical Trials
  • 290 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
Mexico Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Mexico Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 106 Pages
From
Canada Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

Canada Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 165 Pages
From
United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United States Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 980 Pages
From
Diabetes & Obesity Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • Report
  • 560 Pages
From
Bronchopulmonary Dysplasia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Bronchopulmonary Dysplasia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 70 Pages
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • 174 Pages
From
Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021) - Product Thumbnail Image

Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021)

  • Report
  • 141 Pages
From
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report

  • Report
  • 161 Pages
From
Pulmonary Arterial Hypertension (PAH) Market By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonists (ERA), Phosphodiesterase 5 (PDE-5)) And Segment Forecasts To 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Market By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonists (ERA), Phosphodiesterase 5 (PDE-5)) And Segment Forecasts To 2025

  • Report
  • 90 Pages
From
Loading Indicator
adroll